Baretton G, Gille J, Oevermann E, Löhrs U
Institut für Pathologie, Medizinischen Universität zu Lübeck.
Verh Dtsch Ges Pathol. 1990;74:233-7.
The nuclear DNA content of 163 colorectal carcinomas was determined by flow-cytometry (FCM) on formalin-fixed and paraffin-embedded tissue. DNA-aneuploidy was found in 97 cases (59.5%), without correlation to sex, mean age, tumor-stage (DUKES and pTNM) and grading. The frequency of aneuploidy was statistically significantly higher in patients younger than 70 years of age (p less than 0.01) and in tumors localized in the left colon and rectum (p less than 0.002). The tumors in which different areas could be analyzed (n = 80) showed a heterogeneous DNA-ploidy pattern in 18%. The comparison of DNA-content in primaries and in lymph-node metastases (n = 49) resulted in a difference of DNA-ploidy in 38% of the DNA-aneuploid tumors, but only in 6% of the DNA-diploid carcinomas (p less than 0.02). Carcinomas with DNA-aneuploidy showed a trend to a higher rate of loco-regional recurrences, a higher S-phase fraction (13.5% +/- 5.9 vs. 8.1 +/- 7.0), and proved to be associated with a poorer prognosis (p = 0.04). The statistically significantly higher mortality of patients with DNA-aneuploid carcinomas in DUKES A and B stages indicates that DNA-aneuploidy could perhaps be regarded as a stage-independent additional risk factor.
采用流式细胞术(FCM)对163例福尔马林固定、石蜡包埋的结直肠癌组织进行核DNA含量测定。97例(59.5%)发现DNA非整倍体,与性别、平均年龄、肿瘤分期(DUKES分期和pTNM分期)及分级无关。70岁以下患者的非整倍体频率在统计学上显著更高(p<0.01),且左半结肠和直肠肿瘤的非整倍体频率也显著更高(p<0.002)。可对不同区域进行分析的肿瘤(n = 80)中,18%呈现出异质性DNA倍体模式。对原发肿瘤和淋巴结转移灶(n = 49)的DNA含量进行比较,结果显示,在DNA非整倍体肿瘤中,38%的肿瘤存在DNA倍体差异,但在DNA二倍体癌中仅为6%(p<0.02)。DNA非整倍体癌呈现出局部区域复发率更高、S期分数更高(13.5%±5.9对8.1±7.0)的趋势,且预后较差(p = 0.04)。DUKES A期和B期的DNA非整倍体癌患者的死亡率在统计学上显著更高,这表明DNA非整倍体可能可被视为一个与分期无关的额外风险因素。